{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ALT",
        "Security_Name": "Altimmune, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "G",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ALT",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 2,
                "buy": 5,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 2,
                "buy": 5,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 2,
        "previousClose": 14.34,
        "open": 14.38,
        "dayLow": 14.06,
        "dayHigh": 14.58,
        "regularMarketPreviousClose": 14.34,
        "regularMarketOpen": 14.38,
        "regularMarketDayLow": 14.06,
        "regularMarketDayHigh": 14.58,
        "exDividendDate": "2017-01-20T00:00:00.000Z",
        "payoutRatio": 0,
        "beta": 0.473839,
        "forwardPE": 20.414286,
        "volume": 742787,
        "regularMarketVolume": 742787,
        "averageVolume": 1366270,
        "averageVolume10days": 1588970,
        "averageDailyVolume10Day": 1588970,
        "bid": 14,
        "ask": 15,
        "bidSize": 800,
        "askSize": 800,
        "marketCap": 567864576,
        "fiftyTwoWeekLow": 3.83,
        "fiftyTwoWeekHigh": 23.49,
        "priceToSalesTrailing12Months": 163.39752,
        "fiftyDayAverage": 11.6394,
        "twoHundredDayAverage": 10.6936,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.81,
                    "estimate": -0.39
                },
                {
                    "date": "4Q2021",
                    "actual": -0.57,
                    "estimate": -0.65
                },
                {
                    "date": "1Q2022",
                    "actual": -0.44,
                    "estimate": -0.58
                },
                {
                    "date": "2Q2022",
                    "actual": -0.42,
                    "estimate": -0.47
                }
            ],
            "currentQuarterEstimate": -0.5,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1678665600,
                1679011200
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 10331168,
                    "earnings": -39171152
                },
                {
                    "date": 2019,
                    "revenue": 5801401,
                    "earnings": -20520131
                },
                {
                    "date": 2020,
                    "revenue": 8185027,
                    "earnings": -49044477
                },
                {
                    "date": 2021,
                    "revenue": 4410356,
                    "earnings": -97090824
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 157559,
                    "earnings": -33510688
                },
                {
                    "date": "4Q2021",
                    "revenue": 3277658,
                    "earnings": -23889321
                },
                {
                    "date": "1Q2022",
                    "revenue": 32000,
                    "earnings": -19430000
                },
                {
                    "date": "2Q2022",
                    "revenue": 8000,
                    "earnings": -20107000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1678665600,
                1679011200
            ],
            "earningsAverage": -0.5,
            "earningsLow": -0.57,
            "earningsHigh": -0.44,
            "revenueAverage": 870000,
            "revenueHigh": 5000000
        },
        "exDividendDate": "2017-01-20T00:00:00.000Z",
        "dividendDate": "2018-09-14T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-09-16T00:00:00.000Z",
                "firm": "Guggenheim",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-31T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-17T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-12T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-05-18T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-06-30T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-06-30T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-06-30T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-06-16T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-06-02T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-02-11T00:00:00.000Z",
                "firm": "Guggenheim",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-09-25T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-31T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-28T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-07-19T00:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-10-09T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": 0,
        "postMarketChange": 0,
        "postMarketTime": "2023-01-07T00:35:28.000Z",
        "postMarketPrice": 14.29,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": -0.003486764,
        "regularMarketChange": -0.05000019,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 2,
        "regularMarketPrice": 14.29,
        "regularMarketDayHigh": 14.58,
        "regularMarketDayLow": 14.06,
        "regularMarketVolume": 742787,
        "averageDailyVolume10Day": 1588970,
        "averageDailyVolume3Month": 1366270,
        "regularMarketPreviousClose": 14.34,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 14.38,
        "exchange": "NGM",
        "exchangeName": "NasdaqGM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ALT",
        "underlyingSymbol": null,
        "shortName": "Altimmune, Inc.",
        "longName": "Altimmune, Inc.",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 567864576
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 2,
        "enterpriseValue": 366102048,
        "forwardPE": -6.903382,
        "profitMargins": 0,
        "floatShares": 36749658,
        "sharesOutstanding": 39738600,
        "sharesShort": 7050124,
        "sharesShortPriorMonth": 6759783,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.1438,
        "heldPercentInsiders": 0.00715,
        "heldPercentInstitutions": 0.82268,
        "shortRatio": 1.67,
        "shortPercentOfFloat": 0.145,
        "beta": 0.473839,
        "category": null,
        "bookValue": 6.109,
        "priceToBook": 2.3391716,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -96936824,
        "trailingEps": -1.913,
        "forwardEps": 0.7,
        "lastSplitFactor": "1:30",
        "lastSplitDate": "2018-09-14T00:00:00.000Z",
        "enterpriseToRevenue": 105.342,
        "enterpriseToEbitda": -3.966
    },
    "summaryProfile": {
        "address1": "910 Clopper Road",
        "address2": "Suite 201S",
        "city": "Gaithersburg",
        "state": "MD",
        "zip": "20878",
        "country": "United States",
        "phone": "240 654 1450",
        "website": "https://altimmune.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.",
        "fullTimeEmployees": 47,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 14.29,
        "targetHighPrice": 50,
        "targetLowPrice": 14,
        "targetMeanPrice": 29.14,
        "targetMedianPrice": 26,
        "recommendationMean": 1.7,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 7,
        "totalCash": 184756000,
        "totalCashPerShare": 3.809,
        "ebitda": -92302736,
        "totalDebt": 1335000,
        "quickRatio": 13.785,
        "currentRatio": 14.121,
        "totalRevenue": 3475356,
        "debtToEquity": 0.686,
        "revenuePerShare": 0.08,
        "returnOnAssets": -0.24851,
        "returnOnEquity": -0.44486,
        "grossProfits": -71086741,
        "freeCashflow": -36189828,
        "operatingCashflow": -69971944,
        "revenueGrowth": -0.942,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": -26.72447,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}